|
|
Volumn 21, Issue 2, 1993, Pages 241-250
|
|
Roles for in vitro myelotoxicity tests in preclinical drug development and clinical trial planning
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTIVIRUS AGENT;
CAMPTOTHECIN;
CARMUSTINE;
FOSTRIECIN;
HEPSULFAM;
MELPHALAN;
METHOTREXATE;
TOPOTECAN;
ZIDOVUDINE;
ANIMAL CELL;
AREA UNDER THE CURVE;
BONE MARROW TOXICITY;
COLONY FORMATION;
COLONY FORMING UNIT GM;
CONFERENCE PAPER;
CYTOPENIA;
DIAGNOSTIC ACCURACY;
DOG;
DOSE CALCULATION;
DRUG EFFICACY;
FEMALE;
HEMATOPOIESIS;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LABORATORY DIAGNOSIS;
MODEL;
MOUSE;
NONHUMAN;
SPECIES DIFFERENCE;
TREATMENT PLANNING;
ANIMALIA;
CANIS FAMILIARIS;
HUMAN IMMUNODEFICIENCY VIRUS;
MURINAE;
|
|
EID: 0027214520
PISSN: 01926233
EISSN: None
Source Type: Journal
DOI: 10.1177/019262339302100217 Document Type: Conference Paper |
|
Times cited : (60)
|
|
References (0)
|
